Search

Search Constraints

You searched for: Author/Creator Hasenclever, Dirk

Search Results

1. Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19–20 September 2014. Issue 5 (May 2015)

2. Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients—Importance of multimodality imaging: Results from the EuroNet‐PHL‐C1 trial. Issue 4 (3rd February 2021)

4. Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial. Issue 5 (May 2015)

5. High prevalence of severe hypovitaminosis D in patients with advanced gastric cancer treated with first-line chemotherapy with or without anti-EGFR–directed monoclonal antibody (EXPAND trial) showing no prognostic impact. (July 2019)

6. Loss of paraspinal muscle mass is a gender‐specific consequence of cirrhosis that predicts complications and death. Issue 11 (11th November 2018)

8. Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial. Issue 1 (28th August 2019)

9. Rationale and design of a multicentre, randomized, placebo‐controlled trial of mirabegron, a Beta3‐adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3‐left ventricular hypertrophy (Beta3‐LVH). (22nd June 2018)

10. Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial. Issue 1 (January 2022)